Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Umesh, Shukla"'
Publikováno v:
Indian Journal of Health Sciences and Biomedical Research KLEU, Vol 17, Iss 3, Pp 200-208 (2024)
Diabetes mellitus (DM) affects around 537 million people globally, with 77 million cases in India. Type 2 DM is primarily linked to poor dietary habits and sedentary lifestyles, leading to either insulin resistance or impaired insulin secretion. In A
Externí odkaz:
https://doaj.org/article/52e9fc05243f4ee3ab0491d5c72b2e1a
Publikováno v:
Indian Journal of Ayurveda and Integrative Medicine KLEU, Vol 5, Iss 1, Pp 19-24 (2024)
Background: The development of smartphones has caused a dramatic change in societies worldwide. It is one of the best tools that have integrated communication, education, and entertainment. Exploration of the connection between unbalanced use and dif
Externí odkaz:
https://doaj.org/article/82af2acaaa9c4fbb92615844bf127225
Autor:
Umesh Shukla, Nita Radhakrishnan, Bhanu Kiran Bhakhri, Ravi Shankar, Sohini Ghosh, Vikas Jain, Dharmendra K Singh, Devendra K Gupta
Publikováno v:
Asian Journal of Medical Sciences, Vol 12, Iss 3, Pp 10-13 (2021)
Background: Data on the outcome of children with SARS-COV-2 infection (COVID-19) is still evolving as the pandemic unfolds. Aims and Objective: The present study aims at describing the clinical severity, course and outcome of COVID-19 in children
Externí odkaz:
https://doaj.org/article/1fc05bb35d864aacb573409cd875a0b8
Autor:
Harry L A Janssen, Jinlin Hou, Tarik Asselah, Henry L Y Chan, Fabien Zoulim, Yasuhito Tanaka, Ewa Janczewska, Ronald G Nahass, Stefan Bourgeois, Maria Buti, Pietro Lampertico, Oliver Lenz, Thierry Verbinnen, Joris Vandenbossche, Willem Talloen, Ronald Kalmeijer, Maria Beumont, Michael Biermer, Umesh Shukla
Publikováno v:
Gut. BMJ Publishing Group
Scientia
Scientia
ObjectiveWe present the final analysis results of the phase 2 JADE study (ClinicalTrials.gov Identifier:NCT03361956).Design232 patients with chronic hepatitis B (CHB) not currently treated at study start (NCT) at study start or virologically suppress
Publikováno v:
International Journal of Ayurvedic Medicine. 13:878-883
Ayurveda consider cow ghee as healthiest source of dietary fat and have rejuvenating property, improves memory and strengthens nervous, eyes and protects the body from various diseases by balancing all three Doshas (Vata, Pitta and Kaph) and advocate
Autor:
Fabien Zoulim, Christophe Moreno, Samuel S. Lee, Peter Buggisch, Andrzej Horban, Eric Lawitz, Chris Corbett, Oliver Lenz, Bart Fevery, Thierry Verbinnen, Umesh Shukla, Wolfgang Jessner
Publikováno v:
Virology Journal, Vol 15, Iss 1, Pp 1-11 (2018)
Abstract Background Simeprevir is approved with pegylated interferon and ribavirin (PR) for chronic hepatitis C virus (HCV) genotype (GT) 1 and GT4 infection in the USA and the European Union. Methods This 3-year follow-up study assessed the durabili
Externí odkaz:
https://doaj.org/article/12546fb5318c449181ab2d29342193b1
Publikováno v:
JOURNAL OF EXPERIMENTAL ZOOLOGY INDIA. 26:979-992
Autor:
Edward J. Gane, Edwin DeJesus, Ewa Janczewska, Jacob George, Moises Diago, Mariliza Hendrique Da Silva, Henk Reesink, Igor Nikitin, Holger Hinrichsen, Stefan Bourgeois, Peter Ferenci, Umesh Shukla, Ronald Kalmeijer, Oliver Lenz, Bart Fevery, Chris Corbett, Maria Beumont, Wolfgang Jessner
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-13 (2017)
Abstract Background This Phase 3, open-label, rollover study (NCT01323244) investigated the efficacy and safety of simeprevir plus peginterferon α-2a (PegIFNα-2a) and ribavirin (RBV) in a well-characterized population of HCV genotype 1 (GT1)-infect
Externí odkaz:
https://doaj.org/article/3cfa6244d4a94f6ba954c69bc057268c
Publikováno v:
International Journal of Research Publication and Reviews. :2215-2219
The marketing promotion has undergone a phenomenal metamorphosis ever since the smart phone invaded our lifestyle. It is witnessed globally the dominance of the digital means in almost all the spheres of life that allows no option than to adapt and e
Publikováno v:
International Journal of Ayurvedic Medicine. 12:948-953
Background: Prehypertension is classified as elevated blood pressure above normal by American medical classification. JNC 7 suggested systolic between 120 to 139 mmHg or diastolic 80 to 89 mmHg should be consider as Pre-hypertension. Oxidative stress